Caxton Associates (UK)’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,435
Closed -$648K 969
2026
Q1
$648K Buy
3,435
+723
+27% +$152K 0.01% 468
2025
Q4
$539K Hold
2,712
0.01% 487
2025
Q3
$551K Buy
+2,712
New +$481K 0.01% 439

Other funds holding THC

Caxton Associates (UK)'s THC Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 3,435 shares — an estimated $648K sold.

Caxton Associates (UK) first reported a position in THC in Q3 2025 and held it in 3 quarters. The position peaked at $648K in Q1 2026. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 3,435 Tenet Healthcare shares in Q2 2026, an estimated $648K.
  • Caxton Associates (UK) first reported a position in Tenet Healthcare in Q3 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s Tenet Healthcare position peaked at $648K in Q1 2026.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.